99 results on '"Hidaka, Tomonori"'
Search Results
52. Outcome of allogeneic hematopoietic cell transplantation in patients with adult T-cell leukemia
53. Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1
54. Effects of mogamulizumab in adult T-cell leukemia/lymphoma in clinical practice
55. Differences in Hematological and Clinical Features Between Essential Thrombocythemia Cases With JAK2- or CALR-Mutations
56. Development of a complete human IgG monoclonal antibody to transferrin receptor 1 targeted for adult T-cell leukemia/lymphoma
57. TET2 mutation in diffuse large B-cell lymphoma
58. Physiological Expression of Calr Mutant Increases Cell Growth and Cytokine Independency in Human Cell Lines Expressing Mpl, and Develops Essential Thrombocythemia in Mice
59. Mogamulizumab for ATLL in Clinical Practice
60. Next-Generation Sequencing Reveal Proviral Genome and Transcriptome in Adult T-Cell Leukemia/Lymphoma
61. Prognostic Relevance of Integrated Genetic Profiling in Adult T-Cell Leukemia/Lymphoma
62. Frequent Activating Somatic Alterations in T-Cell Receptor / NF-κb Signaling in Adult T-Cell Leukemia/Lymphoma
63. A phase 2 trial of CHOP with anti-CCR4 antibody mogamulizumab for elderly patients with CCR4-positive adult T-cell leukemia/lymphoma.
64. Integrated molecular analysis of adult T cell leukemia/lymphoma
65. Gene expression profiling of loss of TET2 and/or JAK2V617F mutant hematopoietic stem cells from mouse models of myeloproliferative neoplasms
66. TET2 Mutation in Adult T-Cell Leukemia/Lymphoma
67. Nasopharyngeal Carcinoma with Bone Marrow Metastasis: Positive Response to Weekly Paclitaxel Chemotherapy
68. Therapies Targeting the MAPK Pathway Improve Bone Marrow (BM) Fibrosis Induced By JAK2V617F
69. Development and Evaluation of an Index That Predicts Pulmonary Fungal Infection in Patients with Febrile Neutropenia
70. Prognostic Factor, Including Relative Dose Intensity, For Adult T-Cell Leukemia/Lymphoma In Clinical Practice
71. Impact Of TET2 Deficiency On MPN Harboring JAK2V617F Mutation
72. CD3 and EBER double positive cells in bone marrow are a diagnostic aid for EBV-positive T-cell lymphoproliferative disorders of childhood
73. TET2 Is Essential for Survival in Mice, and Decreased TET2 Expression Enlarges HSC Compartment and Alters Cell Differentiation
74. Clinical features and treatment outcomes of isolated secondary central nervous system lymphomas in Miyazaki Prefecture
75. Clinical significance of CADM1/TSLC1/IgSF4 expression in Adult-T cell leukemia/lymphoma (ATLL): identification of various types of ATLL cells
76. NS-018, a Potent Novel JAK2 Inhibitor, Effectively Treats Murine MPN Induced by the Janus Kinase 2 (JAK2) V617F Mutant
77. Potentiated Activation of VLA-4 and VLA-5 Accelerates Proplatelet-Like Formation In Megakaryocytes.
78. Downregulation of CDKN1A in Adult T-Cell Leukemia/Lymphoma despite Overexpression of CDKN1A in Human T-Lymphotropic Virus 1-Infected Cell Lines
79. Absence of Somatically Acquired JAK1 Mutations in Adult T-Cell Leukemia/Lymphoma.
80. Efficacy of R723, a Potent and Selective JAK2 Inhibitor, in JAK2V617F-Induced Murine MPD Model.
81. Alteration of enhancer of polycomb 1 at 10p11.2 is one of the genetic events leading to development of adult T‐cell leukemia/lymphoma
82. Overwhelming Postsplenectomy Infection 22 Years After Splenectomy
83. Critical Role for TSLC1 Expression in the Growth and Organ Infiltration of Adult T-Cell Leukemia Cells In Vivo
84. Summary of the 4th Asian Regional Conference on the Evolution of the System of Radiological Protection
85. Recurrent Chromosomal Rearrangements and a Homozygous Deletion Spanning 1-Mb Region at 10p11.2 in Adult T-Cell Leukemia/Lymphoma.
86. O1-20-6 - Development and Evaluation of an Index That Predicts Pulmonary Fungal Infection in Patients with Febrile Neutropenia
87. CARD11Mutation Induces Oligoclonal Expansion of T-Cells, and Accelerates ATL Development in Combination with HBZ
88. Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan.
89. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
90. Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
91. TET2Mutation Associated with Organ Infiltrations in ATLL
92. Haploinsufficiency of CALRConfers Hematopoietic Stem Cells (HSCs) with a Clonal Advantage over Wild-Type Cells, and, in Setting of Myeloproliferative Neoplasms, Compensates for the Functions of HSCs Impaired By the CalrMutation
93. Predictors of impaired antibody response after SARS-CoV-2 mRNA vaccination in hematopoietic cell transplant recipients: A Japanese multicenter observational study.
94. Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma.
95. [Myeloproliferative neoplasms: revisions in the 2016 WHO criteria].
96. Loss of Tyrosine Kinase 2 Does Not Affect the Severity of Jak2 V617F-induced Murine Myeloproliferative Neoplasm.
97. [Myeloproliferative neoplasms: pathophysiology and therapeutic strategy].
98. [Antiphospholipid syndrome with autoimmune hemolytic anemia which mimics thrombotic thrombocytopenic purpura].
99. [ATL (lymphoma type) presented with a mass formation in the heart].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.